- 製品詳細
- データ表示
- Reviews & Citations
- Important Statement
- Resources


VEGF165 is the predominant isoform of Vascular Endothelial Growth Factor, belonging to the Platelet-Derived Growth Factor (PDGF) family. It serves as a key cytokine regulating angiogenesis and endothelial cell function. During the differentiation of human pluripotent stem cells (hPSCs) toward endothelial cells, VEGF165 drives mesoderm cells toward endothelial progenitors and promotes endothelial cell proliferation, migration, and tube formation. In protocols for differentiation into immune cells, VEGF165 supports the construction of a vascular-like microenvironment, indirectly facilitating the homing and differentiation of hematopoietic stem/progenitor cells. It plays a synergistic role, particularly in the differentiation of myeloid immune cells such as macrophages and dendritic cells, and is often combined with cytokines like SCF, FLT3L, and IL-3 to enhance differentiation efficiency and functional maturation.
GMP Human VEGF165 Protein (GMP-VE5H23) is expressed from human 293 cells (HEK293). It contains AA Ala 27 - Arg 191 (Accession # P15692-4).
Predicted N-terminus: Ala 27

This protein carries no "tag".
The protein has a calculated MW of 19.2 kDa. The protein migrates as 24 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Less than 10 EU/mg, tested by the LAL method in compliance with USP <85> and Ph. Eur. 2.6.14.
<0.5 ng/µg of protein tested by ELISA.
<0.02 ng/μg of protein tested by qPCR.
Sterility testing was performed using the membrane filtration method in compliance with USP <71> and Ph. Eur. 2.6.1.
Negative
>95% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with protectants.
Contact us for customized product form or formulation.
2R (13 mm neck finish)
This product is supplied and shipped on blue ice.
Upon receipt, store it immediately at -20°C or lower for long term storage.
Please avoid repeated freeze-thaw cycles.